.

Make Better Decisions

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Accenture
AstraZeneca
Moodys
Novartis
Colorcon
Teva
Deloitte
Argus Health
Citi
US Department of Justice

Generated: December 17, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 208150

« Back to Dashboard

NDA 208150 describes FLUTICASONE PROPIONATE, which is a drug marketed by Fougera Pharms, G And W Labs, Nesher Pharms, Perrigo New York, Tolmar, Glenmark Generics, Perrigo Israel, Taro Pharm Inds, Apotex Inc, Hi Tech Pharma, West-ward Pharms Int, and Wockhardt, and is included in seventeen NDAs. It is available from seventy-three suppliers. Additional details are available on the FLUTICASONE PROPIONATE profile page.

The generic ingredient in FLUTICASONE PROPIONATE is fluticasone propionate. There are twenty-five drug master file entries for this compound. Eighty-one suppliers are listed for this compound. Additional details are available on the fluticasone propionate profile page.

Summary for 208150

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
Respiratory Tract Agents
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 208150

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
FLUTICASONE PROPIONATE fluticasone propionate SPRAY, METERED;NASAL 208150 ANDA Kaiser Foundation Hospitals 0179-8068 0179-8068-01 1 BOTTLE, SPRAY in 1 CARTON (0179-8068-01) > 120 SPRAY, METERED in 1 BOTTLE, SPRAY
FLUTICASONE PROPIONATE fluticasone propionate SPRAY, METERED;NASAL 208150 ANDA Bayer HealthCare LLC. 0280-0072 0280-0072-15 1 BOTTLE, SPRAY in 1 CARTON (0280-0072-15) > 120 SPRAY, METERED in 1 BOTTLE, SPRAY

Summary for product number 001

Active Rx/OTC/Discontinued:OTCDosage:SPRAY, METERED;NASALStrength0.05MG/SPRAY
Approval Date:Feb 29, 2016TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Boehringer Ingelheim
Merck
Express Scripts
Moodys
Queensland Health
US Department of Justice
Daiichi Sankyo
US Army
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot